4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-12-040002
Chief Operating Officer acquired 102,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Palash Tzvi Chief Operating Officer | 2012-07-16 | Grant or award | +102,000 | 102,000 | I |
Loading xslF345X03/v318902_4.xml…